Progression of Differentiation Induction in Glioma Therapies

Zhu Wenbo
2008-01-01
Abstract:Glioma is the most common one of CNS malignancies,and becomes a challenge because of its refractoriness.To date traditional therapies has no significant effect on prolonging overall survival and improving life quality.Here differentiation therapy has been a novel field in tumor therapies and provides a new method for the management of glioma.Recently there has been a series of differentiation inducers such as retinoic acid,hexamethylenebisacetamide,Sodium phenylbutyrate,cAMP derivate and so on.With the development of associated subjects and technology,differentiation therapy will play a bigger role in the glioma treatment as a supplementary to traditional ones.
What problem does this paper attempt to address?